In the News

1858 News Items found
MSK Healthcare Hero rolls up their sleeve to receive the COVID-19 vaccine.
Help save lives. Get immunized.
Memorial Sloan Kettering medical oncologist Komal Jhaveri
Q&A
Learn about the latest trends in breast cancer research reported at this year’s SABCS meeting.
A section of breast tissue with cancerous changes identified.
In the Lab
By training computers to detect pathological changes in slides of tumor tissue, digital pathology promises to help doctors provide better patient care.
Marcel R.M. van den Brink, MD, PhD
MSK physicians and scientists are involved in notable research to be presented at the meeting and are available to comment on a variety of topics within leukemia, lymphoma, and multiple myeloma.
Josh Foromera wearing a mask
Read about Josh Foromera, who was born in a small village in Zimbabwe and recently began a fellowship in the Gastroenterology, Hepatology, and Nutrition Service at MSK.
Physician-scientist Charles Rudin
In the Clinic
Researchers discover that a subset of lung adenocarcinomas are aggressive because of mutations that allow them to block ferroptosis, a type of cell death.
Structure of an intermediate during the homologous recombination reaction.
The high-resolution views provided by cryo-electron microscopy are helping scientists learn how proteins and DNA collaborate to repair broken DNA.
Nadeem Riaz (left) and Jorge Reis-Filho (right)
Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.
Medical oncologist Alexander Drilon
In the Clinic
For personalized treatment to work, it’s important to analyze each person’s tumor for genetic mutations and find the best drugs to target those mutations.
Systems biologist Joao Xavier in his lab
Finding
MSK researchers have shown for the first time that the concentration of different types of immune cells in the blood changes in relation to the presence of different bacterial strains in the gut.